Kidney transplant recipients who had nonfatal MACE within the first year after transplant surgery, compared with those who did not, had a significantly lower 1-year survival rate (80.5% vs 97.4%).
Patients trust that what they tell their doctors will remain confidential, but under certain specific circumstances, the doctors may be obligated to breach that trust.
The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.